1-7 of 7
Alden A. Moccia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma

Clinical Trials & Observations Brief Report
Ciara L. Freeman, Robert Kridel, Alden A. Moccia, Kerry J. Savage, Diego R. Villa, David W. Scott, Alina S. Gerrie, David Ferguson, Fergus Cafferty, Graham W. Slack, Pedro Farinha, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn
Journal: Blood
Blood (2019) 134 (9): 761–764.
https://doi.org/10.1182/blood.2019000258
Published: 2019
Includes: Supplemental data
Journal Articles

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Valeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, Maurizio Martini, Martina Di Trani, Gabriela Forestieri, Martina Manzoni, Adalgisa Condoluci, Alberto Arribas, Lodovico Terzi-Di-Bergamo, Silvia Laura Locatelli, Elisa Cupelli, Luca Ceriani, Alden A. Moccia, Anastasios Stathis, Luca Nassi, Clara Deambrogi, Fary Diop, Francesca Guidetti, Alessandra Cocomazzi, Salvatore Annunziata, Vittoria Rufini, Alessandro Giordano, Antonino Neri, Renzo Boldorini, Bernhard Gerber, Francesco Bertoni, Michele Ghielmini, Georg Stüssi, Armando Santoro, Franco Cavalli, Emanuele Zucca, Luigi Maria Larocca, Gianluca Gaidano, Stefan Hohaus, Carmelo Carlo-Stella, Davide Rossi
Journal: Blood
Blood (2018) 131 (22): 2413–2425.
https://doi.org/10.1182/blood-2017-11-812073
Published: 2018
Includes: Supplemental data
Journal Articles

Tumor-Associated Macrophages Predict Outcome in Follicular Lymphoma

Robert Kridel, MD, King Tan, MBBS, Abdulwahab J. Al-Tourah, MD, Alden A. Moccia, MD, David W. Scott, MBChB PhD, Graham W. Slack, MD, Joseph M. Connors, MD, Laurie H. Sehn, MD, Christian Steidl, MD, Randy D. Gascoyne, MD
Journal: Blood
Blood (2012) 120 (21): 682.
https://doi.org/10.1182/blood.V120.21.682.682
Published: 2012
Journal Articles

Front-Line Therapy with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) Followed by 2 Years of Rituximab Maintenance for Follicular Lymphoma (FL) Is Associated with Excellent Outcomes and Improved Progression-Free Survival (PFS) In Comparison to No Maintenance

Alden A. Moccia, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Graham W. Slack, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood
Blood (2010) 116 (21): 1803.
https://doi.org/10.1182/blood.V116.21.1803.1803
Published: 2010
Journal Articles

Outcome of Patients with Chemotherapy Refractory and Early Progressive Diffuse Large B Cell Lymphoma After R-CHOP Treatment

Felicitas Hitz, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Paul Hoskins, Alden A. Moccia, Kerry Joanne Savage, MD, BSc, MSc, Laurie H. Sehn, MD, MPH, Tamara Shenkier, Richard Klasa, MD, CM, FRCP(C)
Journal: Blood
Blood (2010) 116 (21): 1751.
https://doi.org/10.1182/blood.V116.21.1751.1751
Published: 2010
Journal Articles

Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)

Alden A. Moccia, Felicitas Hitz, Paul Hoskins, Richard Klasa, Maryse Power, Kerry J. Savage, Tamara Shenkier, John Shepherd, Brian Skinnider, Graham W. Slack, Kevin Song, Randy D. Gascoyne, Joseph M. Connors, Laurie Sehn
Journal: Blood
Blood (2010) 116 (21): 113.
https://doi.org/10.1182/blood.V116.21.113.113
Published: 2010
Journal Articles

R-CHOP with Etoposide Substituted for Doxorubicin (R-CEOP): Excellent Outcome in Diffuse Large B Cell Lymphoma for Patients with a Contraindication to Anthracyclines.

Alden A. Moccia, Kimberly Schaff, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood
Blood (2009) 114 (22): 408.
https://doi.org/10.1182/blood.V114.22.408.408
Published: 2009